{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:06:30Z","timestamp":1768809990659,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Rotterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>We developed a pharmacokinetic model of intravenous sildenafil in newborns with congenital diaphragmatic hernia (CDH) to achieve a target plasma concentration of over 50 \u03bcg\/l.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-three CDH newborns with pulmonary hypertension (64 blood samples) received intravenous sildenafil. Patients received a loading dose of 0.35 mg\/kg (IQR 0.16 mg\/kg) for 3 h, followed by a continuous infusion of 1.5 mg\/kg\/day (IQR 0.1 mg\/kg\/day). For model development, non-linear mixed modeling was used. Inter-individual variability (IIV) and inter-occasion variability were tested. Demographic and laboratory parameters were evaluated as covariates. Normalized prediction distribution errors (NPDE) and visual predictive check (VPC) were used for model validation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A two-compartment disposition model of sildenafil and a one-compartment disposition model of desmethyl sildenafil (DMS) was observed with IIV in sildenafil and DMS clearance and volume of distribution of sildenafil. NPDE and VPC revealed adequate predictability. Only postnatal age increased sildenafil clearance. This was partly compensated by a higher DMS concentration, which also has a therapeutic effect. In this small group of patients, sildenafil was tolerated well.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This model for sildenafil in CDH patients shows that concentration-targeted sildenafil dosing of 0.4 mg\/kg in 3 h, followed by 1.6 mg\/kg\/day continuous infusion achieves appropriate sildenafil plasma levels.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-019-02767-1","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:02:41Z","timestamp":1574103761000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-285X","authenticated-orcid":false,"given":"Suzan C. M.","family":"Cochius - den Otter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Kipfmueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda C. M.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Tibboel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"issue":"4","key":"2767_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.prrv.2007.08.004","volume":"8","author":"PD Robinson","year":"2007","unstructured":"Robinson PD, Fitzgerald DA (2007) Congenital diaphragmatic hernia. Paediatr Respir Rev 8(4):323\u2013334 quiz 334-5","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"2767_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000444210","volume":"110","author":"KG Snoek","year":"2016","unstructured":"Snoek KG et al (2016) Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO consortium consensus - 2015 Update. Neonatology 110(1):66\u201374","journal-title":"Neonatology"},{"issue":"4","key":"2767_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000320622","volume":"98","author":"I Reiss","year":"2010","unstructured":"Reiss I et al (2010) Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO consortium consensus. Neonatology 98(4):354\u2013364","journal-title":"Neonatology"},{"issue":"5","key":"2767_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/SLA.0000000000001533","volume":"263","author":"KG Snoek","year":"2016","unstructured":"Snoek KG et al (2016) Conventional mechanical ventilation versus high-frequency oscillatory ventilation for congenital diaphragmatic hernia: a randomized clinical trial (the VICI-trial). Ann Surg 263(5):867\u2013874","journal-title":"Ann Surg"},{"issue":"2","key":"2767_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.sempedsurg.2007.01.006","volume":"16","author":"JW Logan","year":"2007","unstructured":"Logan JW et al (2007) Mechanical ventilation strategies in the management of congenital diaphragmatic hernia. Semin Pediatr Surg 16(2):115\u2013125","journal-title":"Semin Pediatr Surg"},{"issue":"4","key":"2767_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00008480-200208000-00022","volume":"14","author":"KP Lally","year":"2002","unstructured":"Lally KP (2002) Congenital diaphragmatic hernia. Curr Opin Pediatr 14(4):486\u2013490","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"2767_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/children4080067","volume":"4","author":"Payam Vali","year":"2017","unstructured":"Vali P, Lakshminrusimha S (2017) The fetus can teach us: oxygen and the pulmonary vasculature. Children (Basel) 4(8)","journal-title":"Children"},{"issue":"4","key":"2767_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/bdrc.21085","volume":"102","author":"H Kool","year":"2014","unstructured":"Kool H et al (2014) Pulmonary vascular development goes awry in congenital lung abnormalities. Birth Defects Res C Embryo Today 102(4):343\u2013358","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"2","key":"2767_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000097125","volume":"91","author":"S Noori","year":"2007","unstructured":"Noori S et al (2007) Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 91(2):92\u2013100","journal-title":"Neonatology"},{"issue":"2","key":"2767_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-0033-1357757","volume":"25","author":"A Bialkowski","year":"2015","unstructured":"Bialkowski A, Moenkemeyer F, Patel N (2015) Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia. Eur J Pediatr Surg 25(2):171\u2013176","journal-title":"Eur J Pediatr Surg"},{"issue":"4","key":"2767_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ppul.23935","volume":"53","author":"F Kipfmueller","year":"2018","unstructured":"Kipfmueller F et al (2018) Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia. Pediatr Pulmonol 53(4):452\u2013460","journal-title":"Pediatr Pulmonol"},{"key":"2767_CR12","first-page":"CD005494","volume":"8","author":"LE Kelly","year":"2017","unstructured":"Kelly LE, Ohlsson A, Shah PS (2017) Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev 8:CD005494","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2767_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/clpt.2008.177","volume":"85","author":"A Mukherjee","year":"2009","unstructured":"Mukherjee A et al (2009) Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther 85(1):56\u201363","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2767_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","volume":"33","author":"MD Cheitlin","year":"1999","unstructured":"Cheitlin MD et al (1999) ACC\/AHA expert consensus document. Use of sildenafil (viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association. J Am Coll Cardiol 33(1):273\u2013282","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2767_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/PCC.0000000000000077","volume":"15","author":"S Samiee-Zafarghandy","year":"2014","unstructured":"Samiee-Zafarghandy S, Smith PB, van den Anker JN (2014) Safety of sildenafil in infants*. Pediatr Crit Care Med 15(4):362\u2013368","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2767_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jpeds.2009.06.012","volume":"155","author":"RH Steinhorn","year":"2009","unstructured":"Steinhorn RH et al (2009) Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 155(6):841\u2013847 e1","journal-title":"J Pediatr"},{"issue":"3","key":"2767_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/CCM.0000000000002869","volume":"46","author":"L Leeuwen","year":"2018","unstructured":"Leeuwen L et al (2018) Risk factors of impaired neuropsychologic outcome in school-aged survivors of neonatal critical illness. Crit Care Med 46(3):401\u2013410","journal-title":"Crit Care Med"},{"key":"2767_CR18","unstructured":"Guidance of industry bioanalytical method validation 2001"},{"issue":"1","key":"2767_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM (2007) Diagnosing model diagnostics. Clin Pharmacol Ther 82(1):17\u201320","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2767_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157(6):907\u2013921","journal-title":"Br J Pharmacol"},{"issue":"6","key":"2767_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","volume":"37","author":"EI Ette","year":"1997","unstructured":"Ette EI (1997) Stability and performance of a population pharmacokinetic model. J Clin Pharmacol 37(6):486\u2013495","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2767_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M et al (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13(2):143\u2013151","journal-title":"AAPS J"},{"issue":"2","key":"2767_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentre F (2008) Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Prog Biomed 90(2):154\u2013166","journal-title":"Comput Methods Prog Biomed"},{"issue":"4","key":"2767_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1542\/peds.2005-0523","volume":"117","author":"H Baquero","year":"2006","unstructured":"Baquero H et al (2006) Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117(4):1077\u20131083","journal-title":"Pediatrics"},{"issue":"4","key":"2767_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/tropej\/fmq091","volume":"57","author":"S Uslu","year":"2011","unstructured":"Uslu S et al (2011) A comparison of magnesium sulphate and sildenafil in the treatment of the newborns with persistent pulmonary hypertension: a randomized controlled trial. J Trop Pediatr 57(4):245\u2013250","journal-title":"J Trop Pediatr"},{"issue":"3","key":"2767_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/NPM-16161","volume":"9","author":"S Al Omar","year":"2016","unstructured":"Al Omar S et al (2016) Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study. J Neonatal-Perinatal Med 9(3):251\u2013259","journal-title":"J Neonatal-Perinatal Med"},{"issue":"3","key":"2767_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0029-1239496","volume":"27","author":"A Vargas-Origel","year":"2010","unstructured":"Vargas-Origel A et al (2010) The use of sildenafil in persistent pulmonary hypertension of the newborn. Am J Perinatol 27(3):225\u2013230","journal-title":"Am J Perinatol"},{"issue":"4","key":"2767_CR28","first-page":"159","volume":"73","author":"TR Herrera","year":"2006","unstructured":"Herrera TR, Concha G, Holberto CJ, Loera GRG, Rodriguez BI (2006) Oral sildenafil as an alternative treatment in the persistent pulmonary hypertension in newborns [sildenafil oral como alternativo en el tratamiento de recien nacidos con hipertension pulmonar persistente]. Rev Mex Pediatr 73(4):159\u2013163","journal-title":"Rev Mex Pediatr"},{"issue":"2","key":"2767_CR29","doi-asserted-by":"publisher","first-page":"F109","DOI":"10.1136\/adc.2009.168336","volume":"95","author":"MJ Ahsman","year":"2010","unstructured":"Ahsman MJ et al (2010) Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed 95(2):F109\u2013F114","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2767_CR30","doi-asserted-by":"crossref","unstructured":"Kipfmueller F et al (2018) Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia. Pediatr Pulmonol","DOI":"10.1002\/ppul.23935"},{"issue":"3","key":"2767_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1365-2125.2001.00318.x","volume":"51","author":"R Hyland","year":"2001","unstructured":"Hyland R et al (2001) Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol 51(3):239\u2013248","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2767_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL et al (2003) Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157\u20131167","journal-title":"N Engl J Med"},{"issue":"7","key":"2767_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40262-013-0050-0","volume":"52","author":"I Ince","year":"2013","unstructured":"Ince I et al (2013) A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults. Clin Pharmacokinet 52(7):555\u2013565","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"2767_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/00008571-199712000-00002","volume":"7","author":"JM Treluyer","year":"1997","unstructured":"Treluyer JM et al (1997) Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo\/in-vitro correlation and inducibility. Pharmacogenetics 7(6):441\u2013452","journal-title":"Pharmacogenetics"},{"issue":"3","key":"2767_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1208\/s12248-014-9592-9","volume":"16","author":"K Abduljalil","year":"2014","unstructured":"Abduljalil K et al (2014) Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model. AAPS J 16(3):568\u2013576","journal-title":"AAPS J"},{"issue":"2","key":"2767_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/bcp.13459","volume":"84","author":"JM Brussee","year":"2018","unstructured":"Brussee JM et al (2018) Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure. Br J Clin Pharmacol 84(2):358\u2013368","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2767_CR37","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00134-010-2041-z","volume":"36","author":"ED Wildschut","year":"2010","unstructured":"Wildschut ED et al (2010) Determinants of drug absorption in different ECMO circuits. Intensive Care Med 36(12):2109\u20132116","journal-title":"Intensive Care Med"},{"issue":"5","key":"2767_CR38","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1097\/PCC.0000000000001484","volume":"19","author":"G Raffaeli","year":"2018","unstructured":"Raffaeli G et al (2018) In vitro adsorption of analgosedative drugs in new extracorporeal membrane oxygenation circuits. Pediatr Crit Care Med 19(5):e251\u2013e258","journal-title":"Pediatr Crit Care Med"},{"key":"2767_CR39","doi-asserted-by":"crossref","unstructured":"Ahsman MJ, Wildschut ED, Witjes BCM, Tibboel D, Mathot RAA Population pharmacokinetics of oral sildenafil during and after extracorporeal membrane oxygenation in neonates. in Determinants of pharmacokinetic variability during extracorporeal membrane oxygenation. A roadmap to rational pharmacotherapy in children 2010, Erasmus Medical Center Rotterdam: Rotterdam, The Netherlands p 133-149","DOI":"10.2165\/11319970-000000000-00000"},{"issue":"1","key":"2767_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00228-007-0408-z","volume":"64","author":"G Burgess","year":"2008","unstructured":"Burgess G et al (2008) Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil. Eur J Clin Pharmacol 64(1):43\u201350","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02767-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:11:40Z","timestamp":1605571900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02767-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2767"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02767-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}